Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385949148> ?p ?o ?g. }
- W4385949148 endingPage "4150" @default.
- W4385949148 startingPage "4150" @default.
- W4385949148 abstract "Background: Diffuse large B-cell lymphoma (DLBCL) is a malignant lymphoid tumor disease that is characterized by heterogeneity, but current treatment does not benefit all patients, which highlights the need to identify oncogenic genes and appropriate drugs. G9a is a histone methyltransferase that catalyzes histone H3 lysine 9 (H3K9) methylation to regulate gene function and expression in various cancers. Methods: TCGA and GTEx data were analyzed using the GEPIA2 platform. Cell viability under drug treatment was assessed using Alamar Blue reagent; the interaction between G9a and niclosamide was assessed using molecular docking analysis; mRNA and protein expression were quantified in DLBCL cell lines. Finally, G9a expression was quantified in 39 DLBCL patient samples. Results: The TCGA database analysis revealed higher G9a mRNA expression in DLBCL compared to normal tissues. Niclosamide inhibited DLBCL cell line proliferation in a time- and dose-dependent manner, reducing G9a expression and increasing p62, BECN1, and LC3 gene expression by autophagy pathway regulation. There was a correlation between G9a expression in DLBCL samples and clinical data, showing that advanced cancer stages exhibited a higher proportion of G9a-expressing cells. Conclusion: G9a overexpression is associated with tumor progression in DLBCL. Niclosamide effectively inhibits DLBCL growth by reducing G9a expression via the cellular autophagy pathway; therefore, G9a is a potential molecular target for the development of therapeutic strategies for DLBCL." @default.
- W4385949148 created "2023-08-18" @default.
- W4385949148 creator A5002356832 @default.
- W4385949148 creator A5002446660 @default.
- W4385949148 creator A5002454387 @default.
- W4385949148 creator A5010776316 @default.
- W4385949148 creator A5023259972 @default.
- W4385949148 creator A5026424079 @default.
- W4385949148 creator A5031772152 @default.
- W4385949148 creator A5036138893 @default.
- W4385949148 creator A5040020654 @default.
- W4385949148 creator A5044792340 @default.
- W4385949148 creator A5058348171 @default.
- W4385949148 creator A5058370540 @default.
- W4385949148 creator A5064963677 @default.
- W4385949148 creator A5065669035 @default.
- W4385949148 creator A5067061693 @default.
- W4385949148 creator A5072245275 @default.
- W4385949148 creator A5074331049 @default.
- W4385949148 creator A5076812118 @default.
- W4385949148 creator A5077974758 @default.
- W4385949148 creator A5086609829 @default.
- W4385949148 creator A5089886091 @default.
- W4385949148 date "2023-08-17" @default.
- W4385949148 modified "2023-10-15" @default.
- W4385949148 title "High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach" @default.
- W4385949148 cites W1985819704 @default.
- W4385949148 cites W2001309836 @default.
- W4385949148 cites W2017735587 @default.
- W4385949148 cites W2051456050 @default.
- W4385949148 cites W2098876426 @default.
- W4385949148 cites W2106473601 @default.
- W4385949148 cites W2110345152 @default.
- W4385949148 cites W2119981278 @default.
- W4385949148 cites W2147246240 @default.
- W4385949148 cites W2158267770 @default.
- W4385949148 cites W2253181003 @default.
- W4385949148 cites W2263228961 @default.
- W4385949148 cites W2329713136 @default.
- W4385949148 cites W2418274023 @default.
- W4385949148 cites W2498372051 @default.
- W4385949148 cites W2516587347 @default.
- W4385949148 cites W2537866238 @default.
- W4385949148 cites W2594076746 @default.
- W4385949148 cites W2605112455 @default.
- W4385949148 cites W2618258562 @default.
- W4385949148 cites W2762450632 @default.
- W4385949148 cites W2770460791 @default.
- W4385949148 cites W2797584152 @default.
- W4385949148 cites W2797757758 @default.
- W4385949148 cites W2801763724 @default.
- W4385949148 cites W2898459923 @default.
- W4385949148 cites W2909992178 @default.
- W4385949148 cites W2918959628 @default.
- W4385949148 cites W2946657092 @default.
- W4385949148 cites W2951025322 @default.
- W4385949148 cites W2972778323 @default.
- W4385949148 cites W2981481381 @default.
- W4385949148 cites W3004453399 @default.
- W4385949148 cites W3034704434 @default.
- W4385949148 cites W3036193054 @default.
- W4385949148 cites W3087073121 @default.
- W4385949148 cites W3111569842 @default.
- W4385949148 cites W3127161150 @default.
- W4385949148 cites W3134205746 @default.
- W4385949148 cites W3157999584 @default.
- W4385949148 cites W3160999049 @default.
- W4385949148 cites W3182056440 @default.
- W4385949148 cites W3198157033 @default.
- W4385949148 cites W3205538780 @default.
- W4385949148 cites W4200329532 @default.
- W4385949148 cites W4220972502 @default.
- W4385949148 cites W4281625438 @default.
- W4385949148 cites W4282833750 @default.
- W4385949148 cites W4282913408 @default.
- W4385949148 cites W4283381496 @default.
- W4385949148 cites W4307468223 @default.
- W4385949148 cites W4309446735 @default.
- W4385949148 cites W4310369244 @default.
- W4385949148 cites W4310603204 @default.
- W4385949148 cites W4312018982 @default.
- W4385949148 cites W4317620993 @default.
- W4385949148 cites W4321792359 @default.
- W4385949148 cites W4323257146 @default.
- W4385949148 cites W4323808570 @default.
- W4385949148 cites W4362696055 @default.
- W4385949148 cites W4366985169 @default.
- W4385949148 cites W962365160 @default.
- W4385949148 doi "https://doi.org/10.3390/cancers15164150" @default.
- W4385949148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37627178" @default.
- W4385949148 hasPublicationYear "2023" @default.
- W4385949148 type Work @default.
- W4385949148 citedByCount "0" @default.
- W4385949148 crossrefType "journal-article" @default.
- W4385949148 hasAuthorship W4385949148A5002356832 @default.
- W4385949148 hasAuthorship W4385949148A5002446660 @default.
- W4385949148 hasAuthorship W4385949148A5002454387 @default.
- W4385949148 hasAuthorship W4385949148A5010776316 @default.